Jolanta Stefanski

6.4k total citations
12 papers, 403 citations indexed

About

Jolanta Stefanski is a scholar working on Oncology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jolanta Stefanski has authored 12 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jolanta Stefanski's work include CAR-T cell therapy research (12 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jolanta Stefanski is often cited by papers focused on CAR-T cell therapy research (12 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jolanta Stefanski collaborates with scholars based in United States and Canada. Jolanta Stefanski's co-authors include Isabelle Rivière, Michel Sadelain, Renier J. Brentjens, Clare Taylor, Oriana Bórquez-Ojeda, Daniel Hollyman, Shirley Bartido, Raymond Yeh, Malgorzata Olszewska and Mark Przybylowski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jolanta Stefanski

12 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolanta Stefanski United States 7 353 164 156 140 100 12 403
Martina Schüßler‐Lenz Germany 6 349 1.0× 127 0.8× 180 1.2× 119 0.8× 103 1.0× 9 445
Hannah Karlsson Sweden 6 393 1.1× 134 0.8× 133 0.9× 159 1.1× 107 1.1× 11 435
Andreas Mades Germany 5 430 1.2× 140 0.9× 180 1.2× 157 1.1× 181 1.8× 6 516
Astrid Holzinger Germany 10 341 1.0× 154 0.9× 132 0.8× 111 0.8× 99 1.0× 13 393
Bindu George United States 7 417 1.2× 136 0.8× 156 1.0× 102 0.7× 151 1.5× 22 544
Daosheng Huang China 8 289 0.8× 146 0.9× 187 1.2× 95 0.7× 115 1.1× 12 464
Paulina J. Paszkiewicz United States 4 395 1.1× 173 1.1× 145 0.9× 143 1.0× 142 1.4× 7 471
Katrin Mestermann Germany 4 430 1.2× 149 0.9× 161 1.0× 139 1.0× 178 1.8× 11 493
Sarah A. Richman United States 12 502 1.4× 255 1.6× 220 1.4× 156 1.1× 194 1.9× 14 702
Paul Castillo United States 9 331 0.9× 154 0.9× 130 0.8× 100 0.7× 130 1.3× 34 462

Countries citing papers authored by Jolanta Stefanski

Since Specialization
Citations

This map shows the geographic impact of Jolanta Stefanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Stefanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Stefanski more than expected).

Fields of papers citing papers by Jolanta Stefanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Stefanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Stefanski. The network helps show where Jolanta Stefanski may publish in the future.

Co-authorship network of co-authors of Jolanta Stefanski

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Stefanski. A scholar is included among the top collaborators of Jolanta Stefanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Stefanski. Jolanta Stefanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Xiuyan, Jinrong Qu, Jolanta Stefanski, et al.. (2016). 459. Evaluation of Miltenyi ExpAct and TransAct CD3/28 Beads for CAR-T Cell Manufacturing. Molecular Therapy. 24. S182–S182. 11 indexed citations
2.
3.
Sadelain, Michel, Renier J. Brentjens, Marco L. Davila, et al.. (2014). Abstract CT102: Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Cancer Research. 74(19_Supplement). CT102–CT102. 6 indexed citations
4.
Park, Jae H., Isabelle Rivière, Xiuyan Wang, et al.. (2013). Phase I Trial Of Autologous CD19-Targeted CAR-Modified T Cells As Consolidation After Purine Analog-Based First-Line Therapy In Patients With Previously Untreated CLL. Blood. 122(21). 874–874. 7 indexed citations
5.
Davila, Marco L., Isabelle Rivière, Xiuyan Wang, et al.. (2013). Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy. Blood. 122(21). 69–69. 5 indexed citations
6.
Davila, Marco L., Isabelle Rivière, Xiuyan Wang, et al.. (2012). Molecular Remission and B Cell Aplasia Induced in a First Cohort of Adults with Relapsed B-ALL Treated with 19–28z CAR-Targeted T Cells. Blood. 120(21). 3566–3566. 1 indexed citations
7.
8.
Slovin, Susan F., Xiuyan Wang, Oriana Bórquez-Ojeda, et al.. (2012). Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed CAR+ T cells.. Journal of Clinical Oncology. 30(15_suppl). TPS4700–TPS4700. 7 indexed citations
9.
Hollyman, Daniel, Jolanta Stefanski, Mark Przybylowski, et al.. (2009). Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy. Journal of Immunotherapy. 32(2). 169–180. 234 indexed citations
10.
11.
Quintás‐Cardama, Alfonso, Raymond Yeh, Daniel Hollyman, et al.. (2007). Multifactorial Optimization of Gammaretroviral Gene Transfer into Human T Lymphocytes for Clinical Application. Human Gene Therapy. 18(12). 1253–1260. 26 indexed citations
12.
Gade, T., Waleed Hassen, Elmer Santos, et al.. (2005). Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes. Cancer Research. 65(19). 9080–9088. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Schüßler‐Lenz Breakdown of academic impact, for papers by Hannah Karlsson Breakdown of academic impact, for papers by Andreas Mades Breakdown of academic impact, for papers by Astrid Holzinger Breakdown of academic impact, for papers by Bindu George Breakdown of academic impact, for papers by Daosheng Huang Breakdown of academic impact, for papers by Paulina J. Paszkiewicz Breakdown of academic impact, for papers by Katrin Mestermann Breakdown of academic impact, for papers by Sarah A. Richman Breakdown of academic impact, for papers by Paul Castillo
Rankless by CCL
2026